Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333, clarifying the exact city for this enrollment site. This change improves precision in the study's location listing for Taiwan.
    Difference
    0.0%
    Check dated 2026-05-08T09:28:57.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page’s displayed revision/version footer was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:18:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:06.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    New study sites were added (Columbus, OH; Rabin Medical Center in Israel; Hospital Universitario Vall de Hebron in Spain) and some existing site identifiers were updated.
    Difference
    0.6%
    Check dated 2026-03-26T11:41:14.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0 and the previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:00:00.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a general site version update with no visible changes to study content or navigation.
    Difference
    0.0%
    Check dated 2026-03-12T01:24:06.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.